BC
CORZ icon

Bridgefront Capital’s Core Scientific CORZ Stock Holding History

Bridgefront Capital’s Portfolio CORZ Stock Details CORZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-37,582
Closed -$562K – 554
2026
Q1 		$562K Buy
37,582
+25,215
+204% +$430K 0.14% 242
2025
Q4 		$180K Buy
+12,367
New +$216K 0.05% 472

Other funds holding CORZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SA
Situational Awareness San Francisco, California $20.2B AUM 612.59% 1-Year Est. Return
Jericho Capital Asset Management
Jericho Capital Asset Management New York $12.1B AUM 109.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return
Two Seas Capital
Two Seas Capital Rye, New York $8.68B AUM 78.08% 1-Year Est. Return

Bridgefront Capital's CORZ Position: Q2 2026 in Review

Bridgefront Capital sold out of Core Scientific (CORZ) in Q2 2026, closing a stake of 37,582 shares — an estimated $562K sold.

Bridgefront Capital first reported a position in CORZ in Q4 2025 and held it in 2 quarters. The position peaked at $562K in Q1 2026. 412 funds tracked by Wall St. Rank hold CORZ as of Q2 2026.

  • Bridgefront Capital reported no remaining Core Scientific position as of Q2 2026 after selling out during the quarter.
  • Bridgefront Capital sold 37,582 Core Scientific shares in Q2 2026, an estimated $562K.
  • Bridgefront Capital first reported a position in Core Scientific in Q4 2025 and held it in 2 quarters.
  • Bridgefront Capital's Core Scientific position peaked at $562K in Q1 2026.
  • 412 funds tracked by Wall St. Rank held Core Scientific as of Q2 2026.

Based on Bridgefront Capital's 13F filing for Q2 2026, filed 14 Aug 2026.